Wikidata

(Q80470329)

English

Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation

scientific article published on 01 June 2007

In more languages

Statements

title
Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17565328
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565328%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 December 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q80470329&oldid=2005264857"